Diferencia entre revisiones de «Template:COVID Dex»
Sin resumen de edición |
(Marked this version for translation) |
||
| Línea 2: | Línea 2: | ||
<translate> | <translate> | ||
====[[Special:MyLanguage/Dexamethasone|Dexamethasone]]==== | ====[[Special:MyLanguage/Dexamethasone|Dexamethasone]]==== <!--T:1--> | ||
<!--T:2--> | |||
*Dosage: 6mg Qday for 10 days | *Dosage: 6mg Qday for 10 days | ||
**Dexamethasone improves 28d mortality compared to placebo in patients requiring IMV (NNT = 8.5) and those patients requiring oxygen therapy (NNT = 29). | **Dexamethasone improves 28d mortality compared to placebo in patients requiring IMV (NNT = 8.5) and those patients requiring oxygen therapy (NNT = 29). | ||
**There was no benefit to patients not requiring oxygenation support and potentially harm | **There was no benefit to patients not requiring oxygenation support and potentially harm | ||
</translate> | </translate> | ||
Revisión actual - 07:59 26 ene 2026
Dexamethasone
- Dosage: 6mg Qday for 10 days
- Dexamethasone improves 28d mortality compared to placebo in patients requiring IMV (NNT = 8.5) and those patients requiring oxygen therapy (NNT = 29).
- There was no benefit to patients not requiring oxygenation support and potentially harm